Evidence map›Paper›PMID 24307262›Full record

Trial reportJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2014

Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: results from the CAMONA study.

Björn A Blomberg, Anders Thomassen, Richard A P Takx, Mie H Vilstrup, Søren Hess, Anne L Nielsen, Axel C P Diederichsen, Hans Mickley, Abass Alavi, Poul F Høilund-Carlsen

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. European journal of nuclear medicine and molecular imaging · 2020
    Trial
  2. Trial
  3. Article
  4. Review
  5. American journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Application ofQuantitative imaging in medicine and surgery · 2022
    Article
  11. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  12. Determinants ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  13. Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients usingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  14. (18)F-sodium fluoride PET in multiple myeloma: Linking cancer to atherosclerosis?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  15. Article
  16. Article
  17. International journal of molecular sciences · 2021
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Björn A BlombergDepartment of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense, Denmark, b.a.blomberg@umcutrecht.nl.
Anders Thomassen
Richard A P Takx
Mie H Vilstrup
Søren Hess
Anne L Nielsen
Axel C P Diederichsen
Hans Mickley
Abass Alavi
Poul F Høilund-Carlsen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to determine if delayed sodium (18)F-fluoride (Na(18)F) PET/CT imaging improves quantification of vascular calcification metabolism. Blood-pool activity can disturb the arterial Na(18)F signal. With time, blood-pool activity declines. Therefore, delayed imaging can potentially improve quantification of vascular calcification metabolism. METHODS AND

resultsTwenty healthy volunteers and 18 patients with chest pain were prospectively assessed by triple time-point PET/CT imaging at approximately 45, 90, and 180 minutes after Na(18)F administration. For each time point, global uptake of Na(18)F was determined in the coronary arteries and thoracic aorta by calculating the blood-pool-corrected maximum standardized uptake value (cSUV(MAX)). A target-to-background ratio (TBR) was calculated to determine the contrast resolution at 45, 90, and 180 minutes. Furthermore, we assessed whether the acquisition time-point affected the relation between cSUV(MAX) and the estimated 10-year risk for fatal cardiovascular disease (SCORE %). Coronary cSUV(MAX) (P = .533) and aortic cSUV(MAX) (P = .654) remained similar with time, whereas the coronary TBR (P < .0001) and aortic TBR (P < .0001) significantly increased with time. Even though the contrast resolution improved with time, positive correlations between SCORE % and coronary cSUV(MAX) (P < .020) and aortic cSUV(MAX) (P < .005) were observed at all investigated time points.

conclusionsDelayed Na(18)F PET/CT imaging does not improve quantification of vascular calcification metabolism. Although contrast resolution improves with time, arterial Na(18)F avidity is invariant to the time between Na(18)F administration and PET/CT acquisition. Therefore, the optimal PET/CT acquisition time-point to quantify vascular calcification metabolism is achieved as early as 45 minutes after Na(18)F administration.

Indexed as

AdultAtherosclerosisCalcinosisContrast MediaFemaleFluoroacetatesHumansImage EnhancementMaleMiddle AgedMultimodal ImagingPositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityTomography, X-Ray ComputedContrast MediaFluoroacetatesfluoroacetic acidRadiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.